Pharma & Biotech

Biotechnology leader Amgen finds itself at a critical juncture. The company recently secured a major legal victory that clears a...

While Thermo Fisher Scientific's latest earnings report delivered a powerful performance that delighted the market, the company's strategic direction is...

Replimune Group Inc. has received a substantial confidence boost from regulators, with the U.S. Food and Drug Administration accepting the...

The biotechnology sector is witnessing the emergence of a standout performer, with Arrowhead Pharmaceuticals positioned for potentially significant growth. A...

In a puzzling market reaction, Cassava Sciences witnessed its stock value decline despite achieving a significant legal victory. On Friday,...

German biotechnology firm BioNTech has initiated a significant strategic shift with its $1.25 billion acquisition of competitor CureVac, marking a...

The pharmaceutical company Moderna, once celebrated for its COVID-19 vaccine success, is now confronting a severe crisis of investor confidence....

Ocugen, a specialized biotechnology company, has achieved several critical advancements in recent weeks that signal potential growth for the organization....

Dr. Reddy’s Laboratories ADR presents a complex financial narrative following its Q2 FY26 earnings report, where impressive revenue growth is...

The investment case for Veru presents a study in contrasts. While shares of the biotechnology firm advanced 2.15% to close...